Die Brücken zur Normalität haben sie längst abgebrochen: Wanda, die unverbesserlichen Ekstatiker, die sich selbst und ihren Erfolg als einziges Wunder betrachten. Wenigstens, wenn man die Memoiren des ...

Vier Stunden aus den Welten der Bücher: Die Höhepunkte der besten Lesungen, die wir bei der lit.Ruhr, beim Literaturdistrikt Festival, bei der CrimeCologne und im Polnischen Institut Berlin ...

Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA) candidate clascoterone—both during their first visits, and their seventh ...

Ein neuer, grossformatiger und prächtiger Bildbild aus dem Hause TASCHEN präsentiert alle bekannten Gemälde – davon etliche neu fotografiert – und fast 500 Zeichnungen sowie Druckgrafiken von Albrecht ...

At Cosmo, we eat, sleep, and breathe celebrity relationships—which is why, for the first time ever, we are honoring the celeb couples who define for us what it means to be famous and in love. Some ...

Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone could become a game-changing treatment for male-pattern hair loss. The ...

Shares of Cosmo Pharmaceuticals (OTCPK:CMOPF) soared as much as 24% in Zurich—the biggest jump since 2008—after the company said that its experimental male hair loss treatment met key endpoints in two ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Wanda Eavey Landis, 96, passed away on Sunday, November 23rd at the Chesapeake Retirement Community in Newport News, Virginia, where she had been a resident since 2004. She was predeceased by her ...

A decade after the “Thanksgiving Grandma” invited the then-15-year-old to her holiday dinner in a wrong number mix-up, the pair are still part of each other’s Turkey Day traditions. In a sweet ...

With box office recovery still years away, the company is betting on co-branded IP events, immersive lobbies and social-first experiences to pull young audiences off their phones and back into cinemas ...